Clinical trial
Open-label, Multi-center, Single Arm Study to Evaluate the Efficacy and Safety of Periurethral Injection of Autologous Adipose Derived Regenerative Cells (ADRCs) for the Treatment of Male Stress Urinary Incontinence
NCT02529865 is registered in ClinicalTrials.gov with Nagoya University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open-label, Multi-center, Single Arm Study to Evaluate the Efficacy and Safety of Periurethral Injection of Autologous Adipose Derived Regenerative Cells (ADRCs) for the Treatment of Male Stress Urinary Incontinence
- Lead sponsor
- Nagoya University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 29, 2015
- Completion date
- March 7, 2019
- Enrollment
- 45 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
urinary incontinence , stress